Cross-Linking Mass Spectrometry Service for Protein Complex Structure and Interaction Analysis

Turn protein complex questions into structure-linked evidence with residue-pair proximity mapping, interface insight, and model-guided interpretation.

Cross-Linking Mass Spectrometry Service helps you turn protein complex questions into structure-linked evidence by capturing residue-pair proximity, supporting interface analysis, and adding experimental restraints for model-guided interpretation. Our XL-MS workflows are designed for protein interaction studies, complex assemblies, and structural biology projects that need more than simple interaction confirmation.

When you need more than a simple interaction yes-or-no answer, XL-MS can give you a different level of insight. It can help you understand which residues are close in space, which interfaces are supported by experimental evidence, and how structural restraints can strengthen protein complex analysis.

At Creative Proteomics, we approach XL-MS as a problem-solving service rather than a single experiment. That means we focus on project fit, linker strategy, sample feasibility, confidence-aware data analysis, and structure-ready outputs that help you move from raw identifications to interpretable structural decisions.

What we help you evaluate:

Protein complex interfaces.
Residue-pair proximity information.
Structural restraints for modelling.
Comparative state-dependent interaction changes.
Structure-guided interpretation for complex systems.

Submit Project Requirements

Cross-linking mass spectrometry service overview for protein complex and interaction analysis

What XL-MS Reveals Right Fit Capabilities Workflow Deliverables Demo Sample Comparison Case Study FAQ References

What Cross-Linking Mass Spectrometry Can Reveal About Protein Complexes

Cross-Linking Mass Spectrometry measures spatial proximity between residues by chemically linking amino acids that are close enough to react within a defined distance range. After cross-linking, the protein or protein complex is digested, analyzed by LC-MS/MS, and interpreted through cross-linked peptide identification and structural mapping.

This makes XL-MS especially useful when your question is not only whether proteins interact, but how they are arranged, which regions are likely in contact, and whether those contacts support a specific structural or mechanistic model.

What XL-MS measures: spatial proximity and distance restraints. The core output of XL-MS is a set of cross-linked residue pairs. These can be intra-links within the same protein or inter-links between different proteins or subunits. When filtered and interpreted correctly, these links provide experimentally grounded proximity information that can support topology mapping, interface analysis, and structure refinement.

What kinds of structural questions it supports. XL-MS is particularly valuable when you need to map protein-protein interaction interfaces, support protein complex architecture analysis, compare structural arrangements across states, add experimental restraints to model-guided interpretation, and complement structural readouts from other techniques.

Why it matters for protein complexes and interaction studies. Protein complexes are often difficult to study using a single method. XL-MS gives you a practical way to add experimentally derived structural evidence, especially when you need interface-level support, residue-pair proximity information, or a bridge between biochemical evidence and structural modelling.

When XL-MS Is the Right Fit for Your Project

XL-MS is often the right fit when your project depends on understanding how proteins assemble, interact, or rearrange within a complex system.

Best-fit projects for XL-MS

This service is commonly well suited to purified protein complexes, multimeric protein assemblies, antibody and large biomolecular systems, interaction interface mapping projects, comparative studies across different states or treatments, and structural biology workflows that need experimental restraints.

Sample systems we can discuss

We can discuss projects involving purified proteins, complexes, antibodies, membrane-protein-containing assemblies, and matched state comparisons. If your system is fragile, heterogeneous, or hard to stabilize, early feasibility review becomes especially important.

When another method may be a better first choice

If your main question is about solvent accessibility or broad conformational dynamics, our HDX-MS / HDX-driven Epitope Mapping service may be a better first option. If you mainly need interaction confirmation rather than structure-linked interpretation, Co-IP-MS may be more appropriate.

A useful comparison route for accessibility-focused questions

If you want complementary accessibility data at side-chain level, Covalent labelling mass spectrometry can be a useful comparison route.

How to Choose the Right Strategy for Your Protein Question

Choose XL-MS when you need interface-level support, residue-pair proximity information, structural restraints for model review, or more than simple interaction confirmation.

Add orthogonal methods when you need broader conformational dynamics, stronger validation across different evidence layers, or both structural and functional context.

Start with feasibility review when the complex is fragile or heterogeneous, assembly preservation is critical, the project depends on matched comparison states, or the sample is precious and the design needs to be right before launch.

Request Feasibility Review

Our XL-MS Service Capabilities for Complexes, Interfaces, and Structural Restraints

We built this service for clients who want more than a list of identified cross-links. We support projects that require experimental design, complex-sample handling, structured filtering, and interpretable structural outputs.

AREA 1

Supported sample formats and project types

We can discuss purified protein targets and protein complexes, multimeric assemblies, membrane-protein-related systems, antibody or biologic samples, and matched state comparisons such as control vs treated or wild type vs mutant.

AREA 2

What we review before project launch

Before starting the project, we review the biological question, the target system and subunit context, the expected value of XL-MS for your specific question, sample amount, concentration, purity, and buffer compatibility, and whether the output should emphasize interface mapping, structural restraints, or comparative interpretation.

AREA 3

How we support interpretable structural outputs

Our goal is to help you move from cross-linked peptide identification to structure-linked interpretation. Depending on project fit, that may include residue-pair mapping, protein-pair summaries, restraint-aware filtering, and structure-guided visualization.

AREA 4

Related specialized workflows

If your project involves specialized linker strategies, we can also discuss related workflows such as Photo-crosslinking Structural MS, as well as broader structure-facing approaches like Native ESI-MS for noncovalent complexes and Ion Mobility MS (IM-MS / TIMS-MS).

From Cross-Linking Design to Structure-Ready Results: Workflow and QC Checkpoints

The workflow consists of four essential stages:

Feasibility review, sample context, and linker strategy

We start by reviewing the sample system, project goal, and comparison design. This includes checking sample type, assembly state, buffer context, and whether the project is aimed at interface mapping, structural restraints, or comparative analysis. Typical QC checkpoints include confirmed identity, aligned project goal, reviewed buffer additives, documented assembly or state information, and a linker strategy selected for the intended question.

Cross-linking, digestion, and cross-linked peptide preparation

After the project design is confirmed, the sample enters controlled cross-linking under defined conditions. The cross-linked material is then prepared for peptide-level analysis, including digestion and downstream handling steps appropriate for cross-linked peptide detection. Typical QC checkpoints include conditions matched to sample stability, traceable comparison states, digestion quality, and preserved analytical interpretability.

LC-MS/MS acquisition and cross-linked peptide identification

The prepared sample is analyzed by LC-MS/MS, with the goal of identifying cross-linked peptide pairs that can support confidence-aware structural interpretation. Typical QC checkpoints include sufficient acquisition quality, reviewable cross-linked peptide signals, assignment workflows that support confidence filtering, and data quality suitable for structure-linked analysis.

Filtering, mapping, interpretation, and reporting

After acquisition, the project moves into filtering, mapping, and reporting. This is where raw identifications are turned into something useful: inter- and intra-link summaries, protein-pair mapping, residue-pair interpretation, and structure-aware visualization where appropriate. Typical QC checkpoints include completed confidence filtering, organized link sets, prepared structure-linked interpretation, and deliverables formatted for scientific review.

Vertical XL-MS workflow with QC checkpoints

What You Receive: Deliverables and Data Analysis Support

A strong XL-MS project should give you more than raw files. It should give you a result package that can support internal review, follow-up decisions, and, where appropriate, model-guided structural work.

Core deliverables

Your project package can include raw LC-MS/MS files or equivalent primary outputs, cross-linked peptide identification tables, filtered inter-link and intra-link result sets, protein-pair and residue-pair summaries, annotated figures for review, and method and parameter records where applicable.

Analysis outputs for structural interpretation

Where project fit supports it, we can organize results into interface-linked summaries, residue-pair mapping outputs, structure-guided visual interpretation, and confidence-aware tables for downstream modelling review.

Optional support for model-guided review

If your project needs broader structure-facing context, we can also discuss adjacent methods such as Native ESI-MS for noncovalent complexes or Ion Mobility MS (IM-MS / TIMS-MS) to support a wider interpretation workflow.

Decision-ready outputs

We organize the final package to make it easier for you to review cross-links in a structural context, assess interface relevance, and decide whether follow-up modelling or orthogonal validation is warranted.

Representative XL-MS Results and How They Support Structural Decisions

Integrated XL-MS demo results showing cross-links and structure mapping

Representative result panel for confidence filtering, interface mapping, and structure-guided interpretation

One common result type is a filtered identification set that shows which cross-linked peptide pairs remain after confidence-aware processing. Another common result type maps cross-links back to proteins, subunits, or candidate interfaces. When structural context is available, cross-links can also be mapped onto a 3D complex model to show restraint-supported interfaces or proximity relationships.

Sample Requirements for XL-MS Projects

Good sample design improves the value of the final result. For XL-MS, it is important to think about sample quality, concentration, assembly state, and buffer compatibility before the project begins.

Sample Type	Required Amount	Concentration	Purity	Buffer Conditions	Notes
Protein target	50–200 µg	1–10 µM	≥90% preferred	MS-compatible, no glycerol, low detergents	Provide sequence, tags, and known ligands
Protein complex	100–300 µg	1–5 µM	≥85%	Native buffer preferred	Indicate stoichiometry and cofactors
Membrane protein	200–500 µg	1–5 µM	≥80%	DDM or LMNG acceptable	Provide stabilization conditions
Comparative-state pair	project-specific per state	match states where possible	high purity preferred	keep matrix and buffer consistent	Clarify the comparison design before submission
Antibody or biologic sample	project-specific review	project-specific review	high purity preferred	formulation compatibility should be reviewed early	Share formulation and stress history if relevant

What to prepare before submission:

Sample identity and target details.
Protein sequence or construct information.
Subunit or assembly context.
Concentration and available amount.
Buffer composition and additives.
Matched comparison design, if applicable.
Stability, storage, and handling notes.

Notes for complexes, antibodies, and comparative studies: Complex systems benefit from early feasibility review. If your project depends on preserving assembly state, matched comparison handling, or formulation-sensitive samples, please flag that early so the workflow can be matched to your analytical goal.

XL-MS vs Other Structural and Interaction Methods

Method	Primary Question Answered	Information Type	Best Use	Main Strength	Main Limit
XL-MS	Which residues or regions are close in space?	Residue-pair proximity and structural restraints	Protein complex analysis, interface mapping, model support	Adds structure-linked experimental evidence	Requires careful filtering and interpretation
HDX-MS	Which regions change accessibility or dynamics?	Solvent accessibility and conformational dynamics	State comparison and dynamic behavior	Strong for flexibility and accessibility questions	Does not directly provide residue-pair restraints
Co-IP / Pull-down	Do these proteins interact?	Interaction confirmation	Interaction validation	Practical and direct for confirmation	Limited structural detail
Cryo-EM support workflow	What is the complex architecture?	Structural arrangement	Large complexes and high-resolution interpretation	Powerful structural context	Sample and project burden can be high
AlphaFold / model-guided interpretation	What model is computationally plausible?	Predicted structural arrangement	Early model generation	Fast and useful for hypothesis building	Benefits from experimental restraint support

XL-MS vs HDX-MS. Choose XL-MS when proximity and structural restraint information matter most. Choose HDX-MS when your main question is about dynamics, flexibility, or solvent accessibility.

XL-MS vs co-IP / pull-down. Choose XL-MS when you need structure-linked interpretation. Choose co-IP or pull-down when interaction confirmation alone is enough.

XL-MS as a complement to cryo-EM and structure prediction. XL-MS can be especially useful when you want to support cryo-EM interpretation or add experimental restraint evidence to model-guided protein complex analysis.

Literature Case: XL-MS and Deep Learning for Protein Complex Modelling

Modelling protein complexes with crosslinking mass spectrometry and deep learning

Background

A useful published example comes from a 2024 study that asked whether XL-MS restraints could improve challenging protein complex modelling where structural and co-evolutionary information alone was not enough.

Methods

The authors integrated crosslinking MS-derived restraints into a deep-learning framework for protein complex prediction. Instead of using cross-links only as a post hoc check, they incorporated the restraints into the modelling process and compared the resulting complex predictions against baseline models.

Results

The paper showed that incorporating XL-MS restraints improved modelling performance on difficult protein complex targets. In Fig. 4, the study demonstrated better arrangement of complex components and improved interface placement when cross-link-derived restraints were included. This figure is especially relevant for a service page because it shows how XL-MS can contribute directly to model selection and structure-guided interpretation.

Conclusion

This case supports the value of XL-MS as more than a cross-link identification workflow. It shows how restraint-aware XL-MS data can help strengthen protein complex modelling and make structural decisions more evidence-driven.

Published XL-MS figure showing improved protein complex modelling and structure-guided interface prediction with crosslinking restraints

Fig. 4 from a published 2024 study showing how XL-MS restraints improve protein complex modelling and interface placement.

FAQ

Frequently Asked Questions About XL-MS Service Design and Deliverables

Q: What kinds of protein systems are best suited to XL-MS?

XL-MS is especially useful for protein complexes, multimeric assemblies, antibody-related systems, and interaction studies where structure-linked interpretation matters.

Q: Can XL-MS support protein complex modelling or cryo-EM interpretation?

Yes. XL-MS can provide experimentally grounded restraint information that helps support interface analysis, model review, and structure-guided interpretation.

Q: How do I know whether XL-MS is better than HDX-MS or Co-IP for my question?

That depends on whether you need residue-pair proximity information, accessibility dynamics, or basic interaction confirmation. We review the scientific question first and then discuss the most suitable route.

Q: What sample information is needed before feasibility review?

Please share the sample identity, sequence or construct context, assembly information, available amount, concentration, buffer composition, and the exact question you want the data to answer.

Q: Can XL-MS be used for antibody or large biomolecular assemblies?

Yes. These projects are often good candidates for early feasibility review, especially when structural interpretation or comparability matters.

Q: What kinds of deliverables are included beyond cross-linked peptide lists?

Depending on project fit, deliverables can include filtered link tables, protein-pair summaries, residue-pair mapping, annotated figures, and structure-guided interpretation-ready outputs.

Q: Can XL-MS compare different states, treatments, or assembly conditions?

Yes. Comparative project designs can be useful when the goal is to understand state-dependent rearrangement or interface change.

Q: How are false positives and confidence filtering handled in XL-MS analysis?

Confidence-aware processing, filtering, and structured interpretation are essential parts of the workflow. We treat raw identifications as a starting point, not the final decision layer.

References

Disclaimer

This service is for research use only. It is not intended for clinical, diagnostic, or therapeutic use.

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.